New drug for chronic constipation approved by US Food and Drug Administration
The US Food and Drug Administration has approved plecanatide (Trulance; Synergy Pharmaceuticals) as another option for the treatment of chronic idiopathic constipation (CIC) in adults.
Plecanatide, which should be taken daily, supports regular bowel function by stimulating the upper gastr…
Published: 23 January 2017